| scholarly article | Q13442814 |
| P50 | author | Tracey Shors | Q81878496 |
| Debra A Bangasser | Q85978531 | ||
| Janet Alder | Q42970302 | ||
| P2093 | author name string | Smita Thakker-Varia | |
| Ira B Black | |||
| Parizad M Bilimoria | |||
| Jacob Nettleton | |||
| Jennifer Jernstedt Krol | |||
| P2860 | cites work | Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram | Q73807941 |
| Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication | Q74424004 | ||
| Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor | Q80783829 | ||
| Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects | Q24534868 | ||
| Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity | Q24604536 | ||
| Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior | Q24679793 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus | Q28236724 | ||
| Is mood chemistry? | Q28237445 | ||
| The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression | Q28250177 | ||
| Tachykinins and neuropsychiatric disorders | Q28258576 | ||
| The NPY system in stress, anxiety and depression | Q28279713 | ||
| Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance | Q28504621 | ||
| Hippocampal plasticity involves extensive gene induction and multiple cellular mechanisms | Q28573873 | ||
| Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise | Q28575082 | ||
| VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting | Q28587343 | ||
| Essential role of brain-derived neurotrophic factor in adult hippocampal function | Q28593001 | ||
| Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
| A neurotrophic model for stress-related mood disorders | Q29616291 | ||
| Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
| Hippocampal volume and depression: a meta-analysis of MRI studies | Q30974294 | ||
| A single peripheral injection of basic fibroblast growth factor (bFGF) stimulates granule cell production and increases cerebellar growth in newborn rats | Q31909954 | ||
| Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer | Q33262485 | ||
| Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus | Q33954181 | ||
| Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain | Q33954187 | ||
| VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance | Q33959592 | ||
| Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. | Q33976740 | ||
| Antidepressant-elicited changes in gene expression: remodeling of neuronal circuits as a new hypothesis for drug efficacy | Q33988065 | ||
| Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors | Q34028643 | ||
| Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment | Q34210818 | ||
| Learning enhances the survival of new neurons beyond the time when the hippocampus is required for memory | Q34343344 | ||
| Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment | Q34486424 | ||
| Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain. | Q34588385 | ||
| Neuropeptide Y (NPY) and depression: from animal studies to the human condition | Q34971209 | ||
| Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells | Q36085551 | ||
| Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus | Q36089265 | ||
| Strategies for producing faster acting antidepressants. | Q36101382 | ||
| Males and females respond differently to controllability and antidepressant treatment | Q36175302 | ||
| Hippocampal neurogenesis: regulation by stress and antidepressants | Q36517215 | ||
| Role of neurotrophic factors in depression | Q36627683 | ||
| Behavioral profiling of NPY in aggression and neuropsychiatric diseases | Q36695488 | ||
| Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development | Q36789610 | ||
| Neurogenesis and helplessness are mediated by controllability in males but not in females | Q37217830 | ||
| Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper | Q38306018 | ||
| Serotonin receptor activation leads to neurite outgrowth and neuronal survival | Q40415290 | ||
| Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. | Q42473863 | ||
| Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. | Q42556936 | ||
| Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety | Q42631977 | ||
| The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test | Q42673503 | ||
| 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. | Q42810876 | ||
| Rab3A is required for brain-derived neurotrophic factor-induced synaptic plasticity: transcriptional analysis at the population and single-cell levels. | Q43715950 | ||
| Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. | Q43972766 | ||
| 5-HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells | Q44048558 | ||
| Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. | Q44270223 | ||
| Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells | Q44512246 | ||
| Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain | Q44598165 | ||
| Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone | Q44761977 | ||
| Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex. | Q44771395 | ||
| Oestrogen-deficient female aromatase knockout (ArKO) mice exhibit depressive-like symptomatology | Q44971601 | ||
| Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity | Q45108268 | ||
| Trace fear conditioning depends on NMDA receptor activation and protein synthesis within the dorsal hippocampus of mice | Q45200301 | ||
| Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. | Q45310403 | ||
| Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. | Q45941607 | ||
| Neurotrophin-induced modulation of synaptic transmission in the adult hippocampus | Q46218098 | ||
| Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects | Q46390264 | ||
| Early presynaptic and late postsynaptic components contribute independently to brain-derived neurotrophic factor-induced synaptic plasticity. | Q46402720 | ||
| Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly | Q46604356 | ||
| Transcriptional profiling of brain-derived-neurotrophic factor-induced neuronal plasticity: a novel role for nociceptin in hippocampal neurite outgrowth | Q46891228 | ||
| Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. | Q47351035 | ||
| Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. | Q48120039 | ||
| Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor | Q48162689 | ||
| Intrahippocampal insulin improves memory in a passive-avoidance task in male wistar rats | Q48248762 | ||
| Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. | Q48283271 | ||
| Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor | Q48292564 | ||
| Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine | Q48311985 | ||
| Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. | Q48354279 | ||
| Immediate-early genes and synaptic function | Q48386477 | ||
| Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. | Q48393834 | ||
| Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine | Q48398988 | ||
| Presynaptic modulation of synaptic transmission and plasticity by brain-derived neurotrophic factor in the developing hippocampus. | Q48407674 | ||
| Voluntary exercise and clomipramine treatment elevate prepro-galanin mRNA levels in the locus coeruleus in rats | Q48415029 | ||
| A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment | Q48432020 | ||
| Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. | Q48478412 | ||
| Hippocampal synapsin I, growth-associated protein-43, and microtubule-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats | Q48481817 | ||
| The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity, seizure and lesion. | Q48523285 | ||
| Acute intrahippocampal infusion of BDNF induces lasting potentiation of synaptic transmission in the rat dentate gyrus | Q48530995 | ||
| Lesion-induced proliferation of neuronal progenitors in the dentate gyrus of the adult rat. | Q48631431 | ||
| Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. | Q48635095 | ||
| Regional differences in neurotrophin availability regulate selective expression of VGF in the developing limbic cortex. | Q48707819 | ||
| Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). | Q48824073 | ||
| Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs | Q48886408 | ||
| Expression and polarization of VGF in developing hippocampal neurons | Q48887833 | ||
| Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus | Q48925056 | ||
| Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects | Q48934111 | ||
| Neuropeptide expression in rats exposed to chronic mild stresses | Q49035768 | ||
| Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. | Q49084529 | ||
| A developmentally regulated nerve growth factor-induced gene, VGF, is expressed in geniculocortical afferents during synaptogenesis. | Q51607784 | ||
| Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. | Q52012874 | ||
| Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. | Q52017804 | ||
| Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats | Q73390780 | ||
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12156-67 | |
| P577 | publication date | 2007-11-07 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus | |
| P478 | volume | 27 |
| Q37163613 | Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology |
| Q33893155 | Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment. |
| Q39186841 | An astroglial basis of major depressive disorder? An overview. |
| Q27312650 | An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS |
| Q37346336 | Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus |
| Q36482830 | Brain-derived neurotrophic factor deficiency restricts proliferation of oligodendrocyte progenitors following cuprizone-induced demyelination |
| Q90290199 | Carbamoylated erythropoietin induces a neurotrophic gene profile in neuronal cells |
| Q54388719 | Characterization of the reproductive effects of the anorexigenic VGF-derived peptide TLQP-21: in vivo and in vitro studies in male rats. |
| Q24642070 | Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice |
| Q43099558 | Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. |
| Q48162561 | Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling |
| Q33945946 | Cortical gene transcription response patterns to water maze training in aged mice |
| Q50577146 | DISC1 regulates expression of the neurotrophin VGF through the PI3K/AKT/CREB pathway. |
| Q37119855 | Depletion of central BDNF in mice impedes terminal differentiation of new granule neurons in the adult hippocampus. |
| Q37634525 | Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes |
| Q64325248 | Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression |
| Q36279126 | Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression |
| Q27015084 | Epigenetics of the depressed brain: role of histone acetylation and methylation |
| Q42752136 | Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes |
| Q37393550 | From neurotransmitters to neurotrophic factors to neurogenesis |
| Q91911948 | Grape-derived polyphenols produce antidepressant effects via VGF- and BDNF-dependent mechanisms |
| Q91674760 | H3.3 Barcoding of Nucleus Accumbens Transcriptional Activity Identifies Novel Molecular Cascades Associated with Cocaine Self-administration in Mice |
| Q28547231 | High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid |
| Q37332643 | In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions |
| Q88753838 | Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity |
| Q89441161 | Klotho at the Edge of Alzheimer's Disease and Senile Depression |
| Q40281078 | Lesions of the basolateral amygdala reverse the long-lasting interference with shuttle box escape produced by uncontrollable stress |
| Q39340736 | Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies |
| Q37741989 | Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13). |
| Q41850939 | Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation |
| Q98280964 | Multiscale causal networks identify VGF as a key regulator of Alzheimer's disease |
| Q37399106 | NPAS3 Regulates Transcription and Expression of VGF: Implications for Neurogenesis and Psychiatric Disorders |
| Q34517902 | Neurobiological alterations induced by exercise and their impact on depressive disorders [corrected]. |
| Q35037796 | Neuroendocrine Role for VGF. |
| Q37729262 | Neuropeptide VGF Promotes Maturation of Hippocampal Dendrites That Is Reduced by Single Nucleotide Polymorphisms |
| Q34378979 | Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: its downregulation by DISC1. |
| Q24647788 | Neuropeptides in depression: role of VGF |
| Q35687024 | Neurotrophins role in depression neurobiology: a review of basic and clinical evidence |
| Q37709574 | New approaches to the pharmacological management of major depressive disorder |
| Q35224315 | PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13. |
| Q38062782 | Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-γ systems |
| Q27312115 | Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters |
| Q44079393 | Probing the Conformational Dynamics of the Bioactive Peptide TLQP-21 in Solution: A Molecular Dynamics Study |
| Q33753194 | Profiles of VGF Peptides in the Rat Brain and Their Modulations after Phencyclidine Treatment |
| Q37906804 | Progress in defining the biological causes of schizophrenia |
| Q33568693 | Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing |
| Q47849774 | Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients |
| Q90324876 | Role of a VGF/BDNF/TrkB Autoregulatory Feedback Loop in Rapid-Acting Antidepressant Efficacy |
| Q36345750 | Role of neurotrophins in the development and function of neural circuits that regulate energy homeostasis |
| Q47879810 | Secretogranin III: a diabetic retinopathy-selective angiogenic factor. |
| Q47556392 | Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease. |
| Q92258228 | TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling |
| Q37175279 | Target identification for CNS diseases by transcriptional profiling. |
| Q34463304 | Thalamus-derived molecules promote survival and dendritic growth of developing cortical neurons. |
| Q36851570 | The Role of Neurotrophins in Major Depressive Disorder |
| Q33803824 | The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity |
| Q34661044 | The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment |
| Q36666413 | The extended granin family: structure, function, and biomedical implications |
| Q37702947 | The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure. |
| Q42362126 | The human VGF-derived bioactive peptide TLQP-21 binds heat shock 71 kDa protein 8 (HSPA8)on the surface of SH-SY5Y cells |
| Q24656261 | The molecular neurobiology of depression |
| Q42970228 | The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium |
| Q24649251 | The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism |
| Q47742617 | The requirement of L-type voltage-dependent calcium channel (L-VDCC) in the rapid-acting antidepressant-like effects of scopolamine in mice |
| Q38103493 | The role of inflammatory cytokines on the aetiopathogenesis of depression |
| Q39516883 | Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3. |
| Q28554689 | VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies |
| Q35851548 | VGF and Its C-Terminal Peptide TLQP-62 Regulate Memory Formation in Hippocampus via a BDNF-TrkB-Dependent Mechanism. |
| Q60017595 | VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine |
| Q35822354 | VGF and striatal cell damage in in vitro and in vivo models of Huntington's disease. |
| Q47574847 | VGF function in depression and antidepressant efficacy |
| Q24653586 | VGF, a new player in antidepressant action? |
| Q41495316 | fosB-null mice display impaired adult hippocampal neurogenesis and spontaneous epilepsy with depressive behavior |
Search more.